Acrivon Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Watertown, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Acrivon Therapeutics, Inc. has filed 331 SEC EDGAR filings since 12 Feb 2021

SEC filing history

Showing 276-300 of 331 matching filings.

Per page
25
Current page
12
SC 13G File 005-93824

ACRIVON THERAPEUTICS, INC.

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-93824

SC 13G/A

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-93824

SC 13D

Filing date
28 Nov 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-93824

SCHEDULE 13G

Filing date
28 Nov 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-93824

SC 13G

Filing date
25 Nov 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
21 Nov 2022
Reporting date
17 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
21 Nov 2022
Reporting date
17 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-93824

SC 13G

Filing date
21 Nov 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
21 Nov 2022
Reporting date
17 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
3

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
18 Nov 2022
Reporting date
17 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-93824

SC 13G

Filing date
18 Nov 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-41551

8-K

Filing date
17 Nov 2022
Reporting date
14 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-268426

S-8

Filing date
17 Nov 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Nov 2022
Reporting date
14 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
16 Nov 2022
Reporting date
14 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Nov 2022
Reporting date
14 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Nov 2022
Reporting date
14 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Nov 2022
Reporting date
14 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Nov 2022
Reporting date
14 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Nov 2022
Reporting date
14 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Nov 2022
Reporting date
14 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
16 Nov 2022
Reporting date
14 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-267911

424B4

Filing date
16 Nov 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1MEF File 333-268365

S-1MEF

Filing date
14 Nov 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .